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A B S T R A C T
Purpose: To determine whether celiac children are at risk for EEG-neurological features and sleep
disordered breathing (SDB), and whether an appropriate gluten-free diet (GFD) inﬂuences these
disorders.
Methods: We consecutively enrolled 19 children with a new biopsy-proven celiac disease (CD)
diagnosis. At CD diagnosis and after 6 months of GFD, each patient underwent a general and neurological
examination, an electroencephalogram, a questionnaire about neurological features, and a validated
questionnaire about SDB: OSA (obstructive sleep apnea) scores < 0 predict normality; values > 0
predict OSA.
Results: At CD diagnosis, 37% of patients complained headache that affected daily activities and 32%
showed positive OSA score. The EEG examinations revealed abnormal ﬁnding in 48% of children. After 6
months of GFD headache disappeared in 72% of children and EEG abnormalities in 78%; all children
showed negative OSA score.
Conclusion: According to our preliminary data, in the presence of unexplained EEG abnormalities and/or
other neurological disorders/SDB an atypical or silent CD should also be taken into account.
 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Celiac disease (CD) is a chronic disorder of the small intestine
that occurs in genetically predisposed individuals, with a preva-
lence of 1.16%.1
Although its target organ is the gut, CD is a systemic disorder
that involves many other tissues such as nervous system.2
Diaconu et al. in 2013 studied the incidence of neurologic
manifestations in children with CD showing that one-third of
children presented one or more neurologic symptoms as the onset
manifestation of CD.3
Celiac crisis presenting with status epilepticus and encepha-
lopathy in the absence of profound GI symptom has been recently
described.4
A meta-analysis of the few evidence-based data available on
these disorders in children showed that the relative risk of epilepsy
in individuals with CD, and of CD in individuals with epilepsy,* Corresponding author. Tel.: +39 0633775358; fax: +39 0633775941.
E-mail address: mariapia.villa@uniroma1.it (M.P. Villa).
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1059-1311/ 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights recompared with the general population, was 2.1 and 1.7,
respectively. In the vast majority of these patients, wakefulness
EEGs revealed focal abnormalities, mainly localized in one or both
occipital regions.5
No studies have investigated yet the prevalence of neuronal
hyperexcitability and subclinical electroencephalic (EEG) abnor-
malities in asymptomatic children and adolescents with newly
diagnosed CD before the introduction of a gluten-free diet (GFD),
and in particular any changes following the introduction of
the diet.
On the other hand, studies related to the presence of sleep
disordered breathing (SDB) in CD children have not been
published yet. SDB is a continuum ranging from primary snoring
to obstructive sleep apnea (OSA), which is associated with gas
exchange abnormalities and signiﬁcant sleep fragmentation and
affects 1–5.7% of children.6 SDB is characterized by inﬂamma-
tion, neurological features and autonomic alterations. In our
Pediatric Department there is a referral Pediatric Sleep Centre,
so we usually investigate SDB by a validated simple question-
naire in different groups of patients, also in children at CD
diagnosis.served.
Fig. 1. EEG epochs of patient number 10 of Table 1 showing sharp and rare spikes in
the right temporo-parietal region (A) with sporadic spreading (B) before the gluten-
free diet and normal EEG recorded six months after the diet (C).
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children are at risk for EEG-neurological features and SDB, and
whether an appropriate GFD inﬂuences these disorders.
2. Materials and methods
Nineteen young patients (16 female and 3 male, mean age at
diagnosis 9.82  4.09 years, range 3–17 years) with a new biopsy-
proven CD diagnosis on a free diet were consecutively included in the
study between November 2012 and July 2013 by the Pediatric
Departments of ‘Sapienza’ University of Rome. Each patient under-
went a standardized general and neurological examination, an
electroencephalogram, a questionnaire about neurological features
and a validated questionnaire about SDB. We used OSA score = 1.42
D + 1.41 A + 0.71 S  3.83, where D is difﬁculty breathing during
sleep, A is apnea observed during sleep, and S is snoring. Values
assigned to D and S were O, never; 1, occasionally; 2, frequently; and
3, always. Values assigned to A were 0, no; and 1, yes. OSA scores < 0
predict normality; values > 0 predict OSA.7
Diagnosis of headache was made according to the International
Classiﬁcation of Headache Disorders.8
All of the patients received a GFD and after 6 months each one
was revaluated with general and neurological examination and the
above-mentioned questionnaires; thereafter, patients with abnor-
malities at the ﬁrst awake-EEG exam underwent a new EEG
investigation. Parents conﬁrmed the complete adherence to
the GFD.
Informed consent was obtained from parents.
3. Results
At CD diagnosis all children had normal weight and negative
neurological examination; none of them had allergic rhinitis and/
or nasal congestion, tonsillar hypertrophy was observed only in a
child. General and neurological exams remained unchanged after
treatment. As shown in Table 1, the EEG examinations revealed
abnormal ﬁnding, such as focal or generalized sharps and/or spikes
and spike-waves, in nine children (47.4%) without clear recogniz-
able clinical manifestations. The questionnaire administered at CD
diagnosis showed that seven patients (36.8%) complained head-
ache that affected daily activities and 6 (31.6%) showed a positive
OSA score.
The EEG abnormalities disappeared after 6 months of gluten
exclusion in seven patients out of nine (77.7%); for example, see the
patient number 10 before (A and B) and after (C) in Fig. 1.Table 1
Patients with EEG abnormalities and/or headache and SDB at CD diagnosis and after 6
Patient no. Age at CD
diagnosis,
years
EEG abnormalities
at CD diagnosis,
yes (cerebral
regions) or not
EEG abnormalities
after GFD, yes
(cerebral regions)
or not
1 5.58 Yes (diffuse) Not 
2 7.91 Not Not 
3 9.75 Yes (occipital) Not 
4 10.33 Yes (occipital) Not 
5 16.16 Yes (diffuse) Not 
6 3.16 Yes (diffuse) Not 
7 6.83 Yes (parietal) Not 
8 16.50 Not Not 
9 7.42 Yes (frontal) Yes 
10 14.16 Yes (diffuse) Not 
11 4.33 Not Not 
12 7.00 Not Not 
13 8.67 Yes (diffuse) *
* Parents refused to perform the second EEG.Parents of 1 child refused to perform the second EEG; in the last
remaining child the EEG abnormalities did not change and they
were related to the appearance of ‘‘Eyelid Myoclonia with
Absences’’ (Jeavons Syndrome) which likely was not related to
CD and not responsive to GFD.
After 6 months of GFD headache disappeared in ﬁve children
out of seven (71.4%) and improved in the remaining two children.
All children showed a negative OSA score after diet institution and
without orthodontic, medical or surgical treatment. months of GFD. Patients without these features were not included.
Headache at
CD diagnosis,
yes or not
Headache
after GFD,
yes or not
SDB at CD
diagnosis,
yes or not
SDB after GFD,
yes or not
Not Not Not Not
Yes Not Yes Not
Yes Yes Yes Not
Not Not Not Not
Yes Not Not Not
Not Not Yes Not
Yes Yes Not Not
Yes Not Not Not
Not Not Yes Not
Not Not Not Not
Yes Not Yes Not
Yes Not Not Not
Not Not Yes Not
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This is the ﬁrst prospective trial aimed to investigate the
presence of EEG abnormalities, neurological disorders and SDB in
children with a new CD diagnosis before the GFD, and their
response to the diet.
To the best of our knowledge, no studies have assessed yet the
prevalence of subclinical EEG abnormalities and SDB in children
and adolescents with newly diagnosed CD.
In 47.4% of children we detected EEG abnormalities, particularly
focal or generalized sharps and/or spikes and spike-waves, without
any clinical manifestations before GFD institution; EEG abnormal-
ities disappeared after 6 months of gluten exclusion except for one
child in which a clinical manifestation appeared related to EEG
abnormalities at the second recording (the child affected by
absence eyelid myoclonia).
The lack of study which aims to identify the prevalence of EEG
subclinical abnormalities in newly diagnosed CD does not allow us
to compare our data with other cohort of children. However, it is
important to note that our ﬁndings about the localization of EEG
abnormalities (diffuse, occipital, parietal, and frontal regions) are
in contrast with previous studies since they have demonstrated the
major involvement of the occipital lobe in epilepsy related to CD.9
In the other hand a recent study showed that the prevalence of
CD was higher than the normal population among children with
occipital lobe epilepsy, therefore it is recommended to screen for
CD in these patients.10
Data on the prevalence of headache in CD patients are
controversial: Lahat et al.11 did not ﬁnd a signiﬁcant association,
while Lionetti et al.12 showed a prevalence of 24.8% in a small
series of CD children vs 8% in healthy children and the amelioration
of headache in 76.4% of children on GFD.
Our results show that 36.8% of our CD patients complained
headache. The symptom disappeared in 71.4% of them and
ameliorated in the remaining children after GFD institution. It is
interesting that not a single patient had clinical seizures and in
regard to this we have previously hypothesized that the onset of
clinical symptoms (such as convulsions and other neurological
features) may be preceded by a period in which neuronal
hyperexcitability is expressed exclusively by subclinical electro-
encephalic abnormalities.13
In this matter there is evidence suggesting that the efﬁcacy of a
GFD is inversely related to the duration of neurological disorders
before the initiation of a GFD as well as to the age of the patient at
the start of the GFD.14
However, the pathogenesis of neurological manifestations in
CD has yet to be fully understood but immunological, nutritional
and toxic mechanisms have been suggested.
At the same time we believe that a condition of chronic
inﬂammation such as CD may be a predisposing factor for the
development of SDB and our results (31.6% of children presented a
positive OSA score at CD diagnosis, while in general population the
prevalence of OSA is 1–5.7%) conﬁrm this hypothesis. Surprisinglyafter the diet all patients had negative OSA score without any other
treatment.
Our study presents several limitations: we enrolled a small
sample size and we did not perform the magnetic resonance
imaging; further studies on larger series of children are warranted
to conﬁrm our preliminary results.
It would also be interesting to compare the prevalence of
subclinical EEG abnormalities in this group of children with the
prevalence of the sporadic abnormalities found in a small portion
of the healthy pediatric population15 and to monitor any
abnormalities over time.
According to our preliminary data, in the presence of
unexplained EEG abnormalities and/or other neurological dis-
orders/SDB an atypical or silent CD should also be taken into
account.
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